儿童肺炎干预试验诊断挑战:肺炎现场试验工作组建议
针对降低家庭空气污染以减少儿童肺炎的干预试验,工作组提出设计实施建议:采用结合急性呼吸道症状体征、一般危险体征及辅助检查的标准化病例定义,优先开展医院主动监测而非被动发现或家庭监测,并考虑对1岁以下儿童进行纵向随访。
要点
- 选择结合急性呼吸道症状体征、一般危险体征和辅助检查的标准化病例定义。
- 优先医院主动监测,降低非差异性错分风险及效应量减小。
- 考虑对1岁以下儿童纵向随访,该年龄组重症肺炎发病率最高。
核心结论
- 儿童肺炎干预试验需统一病例定义并优先医院主动监测,以减少错分并保留效应量。
研究设计与样本
- 为筹备降低家庭空气污染以减少儿童肺炎的干预试验,成立工作组提出研究设计与实施建议。
主要发现
- 病例定义和监测方法的选择可显著影响肺炎识别。
- 被动发现或家庭监测增加非差异性错分风险,可能降低随机试验效应量。
- 1岁以下儿童重症肺炎发病率最高。
关键数值与推荐
- 建议采用结合急性(≤14天)呼吸道症状体征、一般危险体征及辅助检查(如胸部影像和脉搏血氧饱和度)的标准化病例定义。
- 建议优先医院主动肺炎监测而非被动发现或家庭监测。
- 建议考虑对1岁以下儿童进行纵向随访。
临床怎么用
- 设计儿童肺炎干预试验时,应预先明确标准化病例定义并采用医院主动监测。
- 对1岁以下儿童可考虑纵向随访以捕捉重症肺炎高发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pneumonia is a leading killer of children younger than 5 years despite high vaccination coverage, improved nutrition, and widespread implementation of the Integrated Management of Childhood Illnesses algorithm. Assessing the effect of interventions on childhood pneumonia is challenging because the choice of case definition and surveillance approach can affect the identification of pneumonia substantially. In anticipation of an intervention trial aimed to reduce childhood pneumonia by lowering household air pollution, we created a working group to provide recommendations regarding study design and implementation. We suggest to, first, select a standard case definition that combines acute (≤14 days) respiratory symptoms and signs and general danger signs with ancillary tests (such as chest imaging and pulse oximetry) to improve pneumonia identification; second, to prioritise active hospital-based pneumonia surveillance over passive case finding or home-based surveillance to reduce the risk of non-differential misclassification of pneumonia and, as a result, a reduced effect size in a randomised trial; and, lastly, to consider longitudinal follow-up of children younger than 1 year, as this age group has the highest incidence of severe pneumonia.
引用
- Goodman D, Crocker ME, Pervaiz F, et al. Challenges in the diagnosis of paediatric pneumonia in intervention field trials: recommendations from a pneumonia field trial working group. Lancet Respir Med. 2019. PMID: 31591066. doi:10.1016/S2213-2600(19)30249-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。